Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 31
PSC Encourages Vioxx MDL Court to Reject Findings of Preemption
Judge Refuses to Certify National Class of Vioxx Injury Plaintiffs
Judge Dismisses Remaining Foreign Class Actions from Federal Vioxx MDL
Plaintiffs Argue Merck Waived Discovery Protection for 'Martin Report'
New Orleans Jury Finds for Merck in 4th Federal Vioxx Trial
Pfizer Says Plaintiffs Failed to Plead Causation, Amend Preempted Claims
PSC Urges MDL Court to Preserve Liability Findings, Grant Remittitur
Court Certifies Limited Class in Canadian Vioxx Action
